Disease Spotlight: Prostate Cancer

Latest News

CMS Issues New Reimbursement Code for PSMA PET Agent POSLUMA
CMS Issues New Reimbursement Code for PSMA PET Agent POSLUMA

September 26th 2023

The transitional pass-through payment reimbursement code for the FDA-approved PSMA PET agent for prostate cancer detection will be effective as of October 1, according to the Centers for Medicare and Medicare Services (CMS).

Can A Deep Learning Algorithm Enhance Detection of Prostate Cancer Recurrence with Biparametric MRI?
Can a Deep Learning Algorithm Enhance Detection of Prostate Cancer Recurrence with Biparametric MRI?

September 26th 2023

Prostate MRI Study Finds Little Difference Between PI-RADS 2.0 and PI-RADS 2.1
Prostate MRI Study Finds Little Difference Between PI-RADS 2.0 and PI-RADS 2.1

September 21st 2023

Study: PET/CT Multivariate Model Enhances Accuracy for Diagnosing Prostate Cancer
Study: PET/CT Multivariate Model Enhances Accuracy for Diagnosing Prostate Cancer

September 13th 2023

Study: ‘All Men with PSAs Between 3 and 20 ng/mL Should Undergo MRI Before Biopsy’
Study: 'All Men with PSAs Between 3 and 20 ng/mL Should Undergo MRI Before Biopsy'

September 7th 2023

More News

© 2023 MJH Life Sciences

All rights reserved.